Correction to previous pressrelease: Active Biotech updates its clinical strategy and projected milestones

Source :: Thomson Reuters ONE. November 24, 2020
Publication Year :: 2020
Abstract: (GLOBE NEWSWIRE via COMTEX) -- Correction: All information was not included in previous pressrelease. PRESS RELEASE, Lund Sweden, November 24, 2020 - Active Biotech (NASDAQ STOCKHOLM: ACTI) Active Biotech AB [...]

Subjects :: Durvalumab
Financial markets
Biotechnology
Ixazomib
Business, international

Tools